MOST NOTEWORTHY: Time Warner Cable (TWC) and Molecular Insight Pharmaceuticals (MIPI) were today's more notable initiations:
- Time Warner Cable (NYSE: TWC) was initiated at Bernstein with an Outperform rating and $46 target, citing a compelling diversification alternative for cable/CMCS investors. Goldman started Time Warner Cable with a Neutral rating and $44 target.
- Molecular Insight Pharmaceuticals Inc (NASDAQ: MIPI) was initiated at RBC with an Outperform rating and $18 target. RBC said Molecular Insight is a leader in developing and commercializing superior radiopharmaceuticals for the treatment and management of life-threatening diseases. Jefferies initiated shares of Molecular Insight with a Buy rating and $20 target, saying Zemiva has blockbuster potential.
OTHER INITIATIONS:
- UBS started Amedisys, Inc (NASDAQ: AMED) with aBuy rating and $39 target.
- Goldman Sachs initiated TransCanada (NYSE: TRP) with a Buy rating.
- Credit Suisse initiated Tim Hortons Inc (NYSE: THI) with an Outperform rating.
- Pacific Growth initiated Ormat Technologies, Inc (NYSE: ORA) with a Buy rating.
Analyst summaries provided by TheFlyOnTheWall.com (subscription required).
.gif){kind=logo}
MOST NOTEWORTHY: Quiksilver, Omniture and Crown Holdings were today's noteworthy upgrades:
The week in preview: Chicken soup (or a doughnut) for the recession-weary soul?
Comfort Zone Investing: Oil's down, which is a start, but not good enough
Stocks have their worst week in six years
